FUJI YAKUHIN

FUJI YAKUHIN was founded in 1930 as a distributor of placement drugs, and is now a diversified pharmaceutical company that operates drugstores and dispensing pharmacies, pharmaceutical manufacturing, pharmaceutical research and development, and prescription drug sales in addition to its placement drug sales business. The Group applies its 1,360 drugstores centering on SEIMS, in addition to a comprehensive nationwide network of placement drug as well as pharmaceutical research and development and manufacturing capabilities, and aims to realize a society in which everyone can lead an abundant life by supporting people in every aspect of their lives and continuing to deliver wellness to them daily. In the prescription drug research and development business, the Group created two drugs with different mechanisms of action for the treatment of gout and hyperuricemia, topiroxostat (product name: TOPILORIC Tablets) and dotinurad (product name: URECE Tablets). With regard to dotinurad, we are working on licensing activities with the aim of contributing to patients around the world who require treatment for gout and hyperuricemia.